The Global Health Academy Heidelberg will be held online, from 2nd to 3rd November 2021. It will bring together students and young professionals and offer a Global Health programme beyond research including trainings, plenary talks, panel discussions, and ePoster presentations.

(see time schedule)


Antimicrobial resistance during COVID-19 pandemic: the role of antimicrobial stewardship by IAPO

Antimicrobial resistance (AMR) is a threat to modern medicine, declared by the WHO as one of the 10 threats to global health. One of the main drivers of AMR is uncontrolled consumption of antimicrobials, and antibiotics in particular.

The ongoing pandemic and the inconclusive findings on what ‘works’ against the SarS-CoV-2 virus, have created additional space and self-justification of self-medication practices, the effects of which we are yet to assess on the increase of AMR and spread of drug-resistant pathogens.

This silent pandemic has to be addressed using different approaches, and Antimicrobial Stewardship (AMS) is one that has shown significant results in some countries.

This 90-minute training session is intended to provide basic guidance and lay a foundation for understanding AMR and key elements of AMS to medical students and young professionals, who will be able and equipped to use their knowledge and skills in an already established AMS team, or be able to convey the knowledge and initiate establishment of AMS team within their facility

Learning objectives:

  • Recognize issues of Antimicrobial Resistance (AMR) across global, national and local levels;
  • Understand and be able to describe the core elements of antimicrobial stewardship (AMS);
  • Know about the impact of COVID-19 on antimicrobial use and on AMR;
  • Be prepared on how AMS can be used to effectively address AMR and what role healthcare providers and patients can play;
  • Be able to effectively join an AMS team or convey the knowledge and skills needed for AMS to both clinical and management teams in hospitals.

Trainers: Jeroen Schouten, Neda Milevska-Kostova

GIS/Geospatial Tools by HeiGIT gGmbH

Introduction GIS Tools /spatial epidemiology

The workshop will introduce some fundamental concepts of how to work with spatial data by using Covid-19 data for Germany using R and RStudio as the analysis environment. We will cover different possibilities for spatial visualization, measures to identify spatial clusters and will sneak into the definition of spatial neighborhood definitions and the consideration of spatial regression analysis in presence of spatial auto-correlation. Hands on exercise are part of the workshop. Experience in using R/RStudio will be beneficial but not mandatory as general concepts are transferable to other analysis environments.

For the hands on exercises it is recommended to install R and Rstudio beforehand using the free versions available at and

Learning objectives

  • Basic concepts of spatial representation and cartography
  • Measures of global and spatial auto-correlation
  • Basics of neighborhood definitions, and spatial regression modelling

Trainer: Sven Lautenbach, Marcel Reinmuth, Steffen Knoblauch

IHR 3.0 Simulator by University of Geneva, EPFL, University Sorbonne Paris Cité and the French Ministry of Health

Health crises of multiple natures – infectious, chemical or nuclear are growing worldwide. International Health Regulation (IHR) allows states and the international community to respond to these challenges. Currently the Covid 19 and before the H1N1 virus, the Ebola virus and the Zika virus, were all declared “Public Health Emergency of International Concern”.

What about tomorrow?

In practice, you will be placed within a management team in real-time for a simulated health crisis occurring in a given country. For 30 minutes, each of you will play a virtual role as a member of one of the following four teams: the Ministry of health of the affected country; other ministries of the country; World Health Organisation; or neighbouring countries. You will follow a news thread displaying the information that will allow you to take the decisions that are the most relevant to the crises within your role.

The IHR 3.0 Simulator was initiated by a consortium of European public universities in consultation with the WHO.   Like a flight simulator for pilots, it aims at virtually training national focal points at distance.  By analysing your responses and behaviours in real-time when placed in a virtual crisis situation, it will identify the potential shortcomings in the training of teams. It will also reinforce learning outcomes concerning the implementation of the International Health Regulations.

In practice, you will be placed within a management team in real-time for a simulated health crisis occurring in a given country. For 30 minutes, each of you will play a virtual role as a member of one of the following four teams: the Ministry of health of the affected country; other ministries of the country; World Health Organisation; or neighbouring countries. You will follow a news thread displaying the information that will allow you to take the decisions that are the most relevant to the crises within your role.

Learning objectives:

Understand the key principles of managing the response to an epidemic emergency

Trainers: Thierry Prieur, Eric Comte

Scientific Writing by HeiSKILLS Center: Teaching & Learning

This training workshop offers an overview of key concepts in scientific writing such as developing an effective writing process, reading with a critical eye, and writing for publication. It covers topics such as structure, drafting, academic language, and revision strategies and touches upon the situatedness of all writing as socially and culturally conditioned. Participants will be asked to reflect on their own writing practices and will have the opportunity to try out new writing tools and methods.

Objectives of the training:

  • describe the different stages of the writing process
  • structure longer science papers according to traditional standards in the English-speaking world
  • provide constructive feedback on their peers’ writing
  • revise and edit their own texts according to the guidelines outlined in the workshop

Trainers: Anne Schindel

Setting up a pop-up collaborative digital environment on the go by BEEKEE

This training will cover the basics on how to rapidly and effectively set up a simple exchange collaboration platform using the digital tool Beekee Live. Next, we will discover how this collaborative tool could be used in challenging circumstances (such as no or patchy internet, power cuts) thanks to a device called the Beekee Box.

Objectives of the training:

Students should be able to grasp the advantages and possibilities of designing scenarios featuring collaborative exchanges amongst peers to enhance learning in authentic scenarios.

Beekee Live platform
Beekee Box

Trainers: Sergio Estupiñán, Vincent Widmer

Upscaling public health education for low- and middle- income countries by OpenWHO

The World Health Organization’s (WHO) open-source learning platform has made online courses available on COVID-19 since January 2020, when the first signs of the approaching pandemic were received.

The OpenWHO team expedited the production of learning materials based on WHO’s evidence-based science in order to serve the rising need for online learning related to COVID-19.

As of June 2021, the COVID-19 pandemic learning surge has expanded the OpenWHO to reach 5.4 million course enrolments from all around the world.

All courses are available for free and the platform allows diverse audiences from around the world to join into the self-paced, asynchronous online learning journey. The emphasis of the platform is on equity and access and aim is to move all barriers for learners. All offerings are therefore provided in no-cost, low bandwidth, mobile-friendly, downloadable and offline formats.

These learning interventions showcase how WHO has been able to transfer scientifically backed knowledge in a fast and scalable way for the public health professionals and speakers will elaborate on the future plans for upscaling and innovating further in this learning domain.

Objectives of the training:

After having participated to the session, the participants will be able to:

  • State the key considerations for a successful asynchronous global learning intervention in health emergencies
  • Rename the access and equity elements of an online learning programs in the public health
  • Describe the online learning uptake in low- and middle-income countries.

Trainers: Ms Heini Utunen, Ms Ngouille Ndiaye, Ms Richelle George

Wikimed Writing to the Public: Health Information for Everyone Else

Probably we can agree that having information, and not misinformation, goes to the heart of dealing with public health issues, be they new diseases like Covid, long term problems like Malaria, or individual health matters. We live in an era in which almost unlimited information is available for minimal cost to anyone who needs it.

But what about everyone else, those with no Internet connection, those lacking facility in a European language? How do we make information available to them? This session will discuss the initiatives of the WikiProjectMed organization to address this situation through a combination of formal presentations, demonstrations, and open discussion.

Trainers: Tim Moody, James Heilman, Gabriel Thullen


The Conference will be accompanied by electronic posters on a wider range of Global Health topis. We particularly encourage students, PhDs, Post-docs and professionals to submit an abstract related to their projects. Abstracts for ePosters can be submitted during the registration process.

Plenary talks

Equity and access to diagnostic tools for COVID-19

Claudia Denkinger
Head Clinical Tropical Medicine, University Clinic Heidelberg, Germany

Claudia Denkinger holds a MD, MSc and DTMH from the Julius-Maximilians University, Germany, and the London School of Hygiene and Tropical Medicine, UK and did her postdoc at McGill University in Epidemiology and Global Health. Her research has focused on diagnostics development and clinical trialling. She has contributed to over 170 publications and has been awarded the Gertrud Meissner Award of the European Society of Mycobacteriology for her contribution to TB research. She led the tuberculosis and hepatitis program at FIND, a WHO collaborating center for Diagnostics over 5 years. Since 2019, Claudia is leading the Division of Infectious Disease and Tropical Medicine at the Heidelberg University Hospital, Germany, where she continues her research work on accelerating the development, assessment and implementation of Global Health relevant diagnostic solutions.

Claudia will be talking about SARS CoV-2 diagnostics – differentiating between personal diagnosis and public health

Human rights and COVID-19

Lisa Forman
Dalla Lana School of Public Health, University of Toronto, Canada

Lisa Forman is an international human rights law scholar whose research explores the contribution of the right to health in international law to remediating global health inequities. She holds a Canada Research Chair Tier 2 in Human Rights and Global Health Equity. In 1993, she completed a BA and LLB at the University of the Witwatersrand in Johannesburg, South Africa, and in 1995, completed articles of clerkship and the qualifying board exams to become a practising lawyer. From 1996-1999, Forman worked as a human rights lawyer on HIV/AIDS at the Centre for Applied Legal Studies at the University of the Witwatersrand, and then as a consultant on HIV/AIDS and human rights at the South African National Commission on Gender Equality. In 2001, Lisa completed a Masters in Human Rights Studies from Columbia University, and in 2006, a Doctorate in Juridical Science (SJD) from the University of Toronto’s Faculty of Law. Her SJD focused on the interaction between right to health in international human rights law and international trade law, and the role of this right in increasing access to AIDS treatment, focusing on the case-study of South Africa. From 2006-2009, Forman completed postdoctoral training at the University of Toronto exploring international human rights law and medicines access in low and middle-income countries. From  2009-2017, she was the Lupina Assistant Professor in Global Health and Human Rights at the Dalla Lana School of Public Health, and Director of the Comparative Program on Health and Society (CPHS) at the Munk School of Global Affairs. She is now a tenured Associate Professor at the Dalla Lana School of Public Health.

Gobal strategies and preventive measures with country examples

Remco van de Pas

Institute of Tropical Medicine, Antwerp, Belgium

Dr. Remco van de Pas is a public health doctor and a global health researcher. He has a position as senior research fellow global health policy at the Institute of Tropical Medicine, Antwerp and is a lecturer in Global health at the Department of Health Ethics and Society, Faculty of Health, Medicine and Life Sciences, Maastricht University.

His teaching and research focuses on global health governance, its political-economy and foreign policy with a special attention on health workforce development and migration, health system strengthening, social protection and health financing, global health security, globalization and its impact on health equity.

Remco is a board member of the Medicus Mundi International–Network Health for All!, a visiting research fellow at Clingendael, Netherlands Institute of International Relations and editorial board member of the academic journal Globalization and Health.        

He worked as health policy adviser for Wemos, a public health foundation advocating for social justice and health equity and as medical coordinator for the NGO Médecins du Monde, of which the largest part in West-Papua, Indonesia. Remco practiced medicine in mental health services for refugees and migrants in Rotterdam.   

His PhD dissertation focuses on global health policy and the international governance of the health workforce and labor migration. The interface between public health, politics, and science potentially enables stronger health systems and equitable health outcomes from a cosmopolitan outlook.   

example India: Rhondemo Kikon

Dr. Rhondemo Kikon is a medical doctor by background and works as a public health specialist. He had completed his MSc in International Health from the Heidelberg Institute of Global Health, University of Heidelberg in 2017. He founded the Community Health Initiative (CHI), an NGO based in Nagaland, India. CHI focuses on strengthening primary health care services, water sanitation and hygiene, nutrition, and livelihood. He has also worked as a health consultant on the National Clinical Registry for COVID-19 a project led by the Indian Council for Medical Research, Government of India. He is passionate towards the formation of evidence-based solutions to health and social challenges. He has been recently awarded the German Chancellor Fellowship by the Alexander von Humboldt Foundation and is currently pursuing his research project on childhood obesity preventative strategies at the Heidelberg Institute of Global Health, University of Heidelberg.

Example Peru: Alejandra Bussalleu

Alejandra Bussalleu is the Research Program Coordinator for Global NCD’s NIH Household Air Pollution Investigation Network (HAPIN) study in Puno, Peru. She holds a BSc in Biology from Universidad Peruana Cayetano Heredia in Peru, and a MSc in Global Health from Ruprecht-Karls-Universität Heidelberg in Germany. Alejandra is an associate researcher at the Intercultural Citizenship and Indigenous Health Unit, at the School of Public Health and Administration of the Universidad Peruana Cayetano Heredia, and has experience in project management and research focused on the health effects of environmental change among indigenous communities of the Peruvian Amazon. She is an advisor and consultant for various projects related to the revaluation of Traditional Amazonian Medicine, health promotion in indigenous communities, the development of Amazonian art and cultural expression, among others.

Virology SARS-CoV-2

Clara Lehmann

Cologne University Hospital

Prof. Dr. Clara Lehmann studied medicine in Cologne and Paris from 1996-2003. She began her clinical work in 2003 at the University Clinic in Cologne. During her Post Doc studies between  2008 – 2010,  she worked  at the Institute of Human Virology, Baltimore, USA in the laboratory of Professor Robert Gallo  with a focus on HIV immunology. In 2012 she became a specialist in internal medicine, since 2014 with the additional qualification in infectious diseases (DGI and LÄK). Since 2015 she has taken over the management of the infection outpatient clinic at Cologne University Hospital. She completed her habilitation in internal medicine in 2014.
Since the onset of the SARS CoV 2 Pandemic she is heading the Infection Control Centre and outpatient service and is involved as investigator in several ongoing clinical and vaccine trials.  

Panel discussion: Global control of COVID-19 – what needs to be done?

Karl Lauterbach

Karl Lauterbach (born 1963) is full professor of Health Economics and Clinical Epidemiology at the University of Cologne (Germany), Member of the Deutsche Bundestag

(MdB) and an Adjunct Faculty Member of the Department of Health Policy and Management at the Harvard School of Public Health (Boston). He studied in Medicine in Aachen and in Dusseldorf (Germany) and in San Antonio (Texas, US) and received his first doctoral degree at the Institute of Nuclear Medicine at the Nuclear Research Centre in Julich (Germany).

He studied health policy and management and epidemiology as a post-doc at the Harvard School of Public Health, Boston, USA, and received a degree as a Master of Public Health and as a Doctor of Science (Sc.D.) in Health Policy and Management. He was a fellow of the Program of Ethics and the Professions at Harvard (1992) and a fellow in Medical Ethics at the Harvard Medical School (1993). Since 1998 Prof. Lauterbach is Director of the Institute of Health Economics and Clinical Epidemiology at the University of Cologne Medical School, Germany. Since 2005 he is Member of the Deutsche Bundestag for the Social Democratic Party (SPD). From 2013 to 2019 he was deputy chairman of the Social Democratic parliamentary group. Since 2008 Prof. Lauterbach is also an Adjunct Professor of Health Policy and Management at tthe Department of Health Policy and Management, Harvard University.

Catherine Kyobutungi

Executive Director of the African Population and Health Research Center, Nairobi, Kenya. Her main research interests are non-communicable diseases in Africa and maternal health. In 2019 she was appointed the Joep Lange Chair. She also serves as director of the Consortium for Advanced Research Training in Africa (CARTA), an organisation which looks to rebuild and strengthen the capacity of African universities. She is a member of the African Academy of Sciences and, since 2019 a member of the Lancet–SIGHT Commission on Peaceful Societies Through Health and Gender Equality.

Michael Stolpe

Michael Stolpe leads the project area Global Health Economics at the Kiel Institute for the World Economy (IfW).  He is a founding member of the DFG Cluster of Excellence „Precision Medicine“ and is involved as Principal Investigator in the Leibniz Research Network „INFECTIONS in an Urbanising World – Humans, Animals, Environment (InfUrb)“. His other research focuses on health inequalities, health investments over the life cycle, health-related early retirement and pension policies, the social costs of HIV/AIDS, medical decision-making, methods of economic evaluation, and innovations in medical technology and their diffusion in health care. He is Associate Editor of the interdisciplinary social sciences and humanities research journal Humanities and Social Sciences Communications published by Springer Nature.  Since 2011, Michael Stolpe has also been a member of the Editorial Board of the Health Economics Review. 

Sam Phiri

Sam Phiri is a Programs Director at Partners in Hope Malawi providing Strategic Leadership to a large PEPFAR/USAID supported HIV Care and Treatment Program. Before he was Executive Director of Lighthouse Trust in Malawi over 20 years managing PEPFAR/CDC Care and Treatment program. Sam Phiri is an accomplished implementation scientist with large body of published work in areas of PMTCT, ART, TB, and NCD integration. His interest is Treatment and Care; Operational Research in Infectious Diseases particularly Sexually Transmitted Infections, HIV & AIDS and TB. Dr Phiri is a Professor in Department of Medicine at University of North Carolina School of Medicine at Chapel Hill, USA, Department of Global Health at University of Washington in Seattle, USA and Faculty at University of Malawi, College of Medicine, School of Public Health and Family Medicine.

Malay Kanti Mridha

Dr Malay Kanti Mridha is a Professor of the BRAC James P Grant School of Public Health of BRAC University, Dhaka, Bangladesh. He is an internationally recognized scientist and leader in public health, non-communicable diseases, and nutrition. He has a unique combination of expertise in medicine, public health, epidemiology, non-communicable diseases, public health nutrition, public health studies and programs, training, teaching, academic supervision. He is also leading a research center of excellence for non-communicable diseases and nutrition. With co-authors, he published more than 134 original research articles and research reports. He received grants from the US Agency for International Development, World Health Organization, the World Bank, Bill and Melinda Gates Foundation, Food and Agriculture Organization, Global Alliance for Improved Nutrition, United Nations Children Fund, Enfants du Monde, UK National Institute for Health Research, Wellcome Trust, Government of Bangladesh, Japan International Cooperation Agency, Nutrition International, HarvestPlus, UK Department for International Development, and Australian Aid. As the founding Director of the research center of excellence for non-communicable diseases and nutrition of BRAC University, he is currently in charge of implementing a comprehensive research agenda to control and prevent non-communicable diseases and malnutrition in Bangladesh and the global South. During the COVID-19 pandemic, he led epidemiological modeling and the assessment of the impact of COVID-19 on the health and well-being of the South-Asian population. 

Michaela Pfeiffer

Michaela is a Senior Technical Officer in the Director General’s office at the World Health Organization (WHO).  Originally trained in bio-chemistry, she is a public health expert and has worked for WHO for more than 15 years on operational, technical and strategic issues at the country, regional and global levels.

She joined the Access to COVID-19 Tools (ACT) Accelerator’s Executive Hub in April 2020 when the ACT-Accelerator partnership was first launched. Michaela plays a leading role in managing the Hub’s day-to-day operations and recently coordinated the multi-agency, multi-partner process to develop the ACT-Accelerator’s new strategic plan and budget for the period October 2021 to September 2022.

In addition to her role in the ACT-A Hub, Michaela is a core member of the Director-General’s transformation team and is helping drive changes to WHO’s overall operating model and core technical, business and external relations processes to help optimize WHO’s ways of working and the impact of its work on people’s health in all countries. 

Astrid Berner-Rodoreda (Moderator)

Astrid Berner-Rodoreda has more than 20 years of NGO experience in international development work with a strong focus on HIV and national and international advocacy for equitable access to prevention and treatment. She served as a board member of the Ecumenical Pharmaceutical Network, Action against AIDS and on steering and strategy groups for a number of international networks. She is a founding member of the People’s Health Movement, Germany and is currently pursuing a PhD at the Heidelberg Institute of Global Health focusing on men and HIV while also coordinating an international ethics project on health policy experiments. Her research interests include health policies, global treatment access and HIV and gender.